Wire · regulatory
With Trump's nominee pick in, FDA weighs new deputy commissioner posts: report
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 August 2026 · Fusion42 review
The FDA is considering adding two new deputy commissioner roles focused on technology, including AI, and drugs under the anticipated leadership of Trump's nominee Heidi Overton, signaling a strategic priority shift towards AI in healthcare regulation.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 5 sources have reported it between 25 Aug 2026 and 26 Aug 2026.
◆ ◆ The Wire takeaway
You need to prepare for tighter integration of AI oversight in FDA processes as new deputy roles elevate technology regulation. This change opens new pathways for Healthtech Infrastructure startups to influence and collaborate with the FDA early.
◆ Coverage
5 sources · first reported 25 Aug 2026 · latest 26 Aug 2026
◆ Related on Wire
◆ Topics